Cost-effectiveness and budget impact analysis of lisdexamfetamine versus methylphenidate for patients under 18 with attention-deficit/hyperactivity disorder in Iran

• मुख्य लेखकों: Amirmohammad Tajik (लेखक), Shekoufeh Nikfar (लेखक), Sepideh Elyasi (लेखक), Omid Rajabi (लेखक), Mehdi Varmaghani (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2023-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Lisdexamfetamine (LDX) and Methylphenidate (MPH) are stimulant agents that have been shown to provide significant benefits in the management of attention-deficit/hyperactivity disorder (ADHD) in patients. Aim This study aimed to assess the cost-effectiveness and the budget impact...